Výsledky vyhledávání - "Guang Chuan Xu"

Chemotherapy with concurrent brain and thoracic radiotherapy in brain-only metastases of treatment naive small-cell lung cancer: a phase II study

Autor: Guo Zhen Liu, Wei Dong Wei, He Huang, Yin Duo Zeng, Xiao Xiao Dinglin, Guang Chuan Xu, Li Kun Chen, Hai Liao

Publikováno v: Medical Oncology. 29:1687-1692

To study the treatment outcomes of brain-only metastases from small-cell lung cancer (SCLC) at initial diagnose treated by chemotherapy with concurrent brain and thoracic radiotherapy (RT). From Jan 2004 to Jan 2009, 36 treatment-naïve SCLC patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69f10b88f433470d34d55293c853474d
https://doi.org/10.1007/s12032-011-0040-8

Zobrazit plný text záznamu

Triplet platinum-based combination sequential chemotherapy improves survival outcome and quality of life of advanced non-small cell lung cancer patients

Autor: Li Kun Chen, Qun Ying Yang, Guo Zhen Liu, Guang Chuan Xu, Ying Liang, Ning Ning Zhou, Wei Dong Wei, Fei Xu

Publikováno v: Asian Pacific journal of cancer prevention : APJCP. 13(5)

Background Maintenance chemotherapy is one strategy pursued in recent years with intent to break through the chemotherapy plateau for advanced non-small cell lung cancer (NSCLC). However, given the toxicity, platinum-based combinations are rarely giv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49060547d6d51273f7fa54d7ad8bf29a
https://pubmed.ncbi.nlm.nih.gov/22901137

Zobrazit plný text záznamu

[Analysis of the efficacy and safety of gefitinib in the treatment of recurrent advanced non-small cell lung cancer in an expanded access program (EAP)]

Autor: He, Huang, Yang, Zhang, Hong-yun, Zhao, Zhi-qiang, Wang, Fei, Xu, Guang-chuan, Xu, Li, Zhang, Zhong-zhen, Guan

Publikováno v: Zhonghua zhong liu za zhi [Chinese journal of oncology]. 31(2)

The aim of this study is to evaluate the efficacy and safety of Gefitinib in the treatment of Chinese patients with recurrent advanced non-small-cell lung cancer (NSCLC).120 patients were enrolled in this trial from September 2002 to March 2005, and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::21087f1dc795ac09ed145cb06fd1c282
https://pubmed.ncbi.nlm.nih.gov/19538895

Zobrazit plný text záznamu

[Efficacy of erlotinib on advanced non-small cell lung cancer]

Autor: Hong-Yun, Zhao, Yang, Zhang, He, Huang, Li-Kun, Chen, Guang-Chuan, Xu, Li, Zhang

Publikováno v: Ai zheng = Aizheng = Chinese journal of cancer. 27(4)

Erlotinib is a selective inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, and has been used in treating advanced non-small cell lung cancer (NSCLC). This study was to evaluate the efficacy of erlotinib on advanced NSCLC, and obse

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3c57a79c96d5eb61d07ba3c88c401fcc
https://pubmed.ncbi.nlm.nih.gov/18423126

Zobrazit plný text záznamu

[Responses of 109 adult soft tissue sarcoma patients to chemotherapy]

Autor: Miao-Zhen, Qiu, Fei, Xu, Shu-Sen, Wang, Hui-Yan, Luo, Feng, Wang, Fang-Hua, Li, Xiao-Fei, Sun, Guang-Chuan, Xu, Tong-Yu, Lin, Hui-Qiang, Huang, Wen-Qi, Jiang, Zhong-Zhen, Guan, Rui-Hua, Xu

Publikováno v: Ai zheng = Aizheng = Chinese journal of cancer. 26(12)

The response of adult soft tissue sarcoma (STS) to chemotherapy is uncertain. This study was to evaluate the role of chemotherapy in treating adult soft tissue sarcoma.Clinical data of 109 adult soft tissue sarcoma patients, treated with chemotherapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::03531387cffebf0a68414f32d7491ffe
https://pubmed.ncbi.nlm.nih.gov/18076798

Zobrazit plný text záznamu

[Nadaplatin or cisplatin combined with paclitaxol in treatment for non-small cell lung cancer: a randomized controlled study]

Autor: Li-Kun, Chen, Guang-Chuan, Xu, Zhong-Zhen, Guan, Ying, Hang, Qun-Ying, Yang

Publikováno v: Zhonghua zhong liu za zhi [Chinese journal of oncology]. 29(6)

To investigate the therapeutic effect, long term survival and side effect on NSCLC patients treated with nadaplatin combined with paclitaxol and cisplatin combined with paclitaxol.NSCLC patients with stage IIIB or IV were randomized into two groups i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::55b44009cbcae6ff22a19525edcadd84
https://pubmed.ncbi.nlm.nih.gov/17974278

Zobrazit plný text záznamu

[Primary breast lymphoma--a report of 27 cases with literature review]

Autor: Ya-Bing, Cao, Shu-Sen, Wang, Hui-Qiang, Huang, Guang-Chuan, Xu, You-Jian, He, Zhong-Zhen, Guan, Tong-Yu, Lin

Publikováno v: Ai zheng = Aizheng = Chinese journal of cancer. 26(1)

Primary breast lymphoma (PBL) is an uncommon disease with poor clinical outcome. This study was to investigate clinicopathologic features and optimal treatment of PBL.Clinical records of 27 PBL patients, treated in Cancer Center of Sun Yat-sen Univer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3c82f96d46e3c10c20089d5c0ac6551f
https://pubmed.ncbi.nlm.nih.gov/17222374

Zobrazit plný text záznamu

[Efficacy of gefitinib on advanced non-small cell lung cancer in expanded access program (EAP)]

Autor: Yang, Zhang, Li, Zhang, Fei, Xu, Zhi-Qiang, Wang, Hong-Yun, Zhao, Zhong-Zhen, Guan, Guang-Chuan, Xu, Zhen-Kui, Pan

Publikováno v: Ai zheng = Aizheng = Chinese journal of cancer. 25(12)

Gefitinib is a selective inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, and has been used in treating advanced non-small cell lung cancer (NSCLC). This study was to evaluate the efficacy of Gefitinib on advanced NSCLC, and obse

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::72c6c531ff19cd363b211703d66f169a
https://pubmed.ncbi.nlm.nih.gov/17166387

Zobrazit plný text záznamu

[Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer]

Autor: Wei-Hua, Wang, Yong, Bao, Ming, Chen, Li, Zhang, Kai-Xin, Li, Guang-Chuan, Xu, Xiao-Wu, Deng, Tai-Xiang, Lu, Nian-Ji, Cui

Publikováno v: Ai zheng = Aizheng = Chinese journal of cancer. 25(10)

The efficacy of radiotherapy alone on locally advanced non-small cell lung cancer (NSCLC) is poor. Although the combined modality of chemoradiotherapy and dose-escalation of radiotherapy have been the main trends, the optimal modality still remains u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::94abda12039bfb3735f26a2c14fb8d74
https://pubmed.ncbi.nlm.nih.gov/17059776

Zobrazit plný text záznamu

[Intrapericardial infusion of etoposide and cisplatin in treating malignant pericardial effusion of non-small cell lung cancer]

Autor: Li-Kun, Chen, Guang-Chuan, Xu, Ying, Liang, Qun-Ying, Yang, Li-Na, Zhang

Publikováno v: Ai zheng = Aizheng = Chinese journal of cancer. 25(4)

Pericardiocentesis and intrapericardial infusion of chemotherapeutic drugs is the main treatment of malignant pericardial effusion. This study was to observe the efficacy and side effect of intrapericardial infusion of etoposide (VP-16) and cisplatin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e3a38ed32ab15b123a865761a7ef77b8
https://pubmed.ncbi.nlm.nih.gov/16613690

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání